L'Occitane International SA
F:COC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L'Occitane International SA
F:COC
|
LU |
|
5
|
5E Advanced Materials Inc
ASX:5EA
|
US |
|
Elevation Oncology Inc
NASDAQ:ELEV
|
US |
|
Midwich Group PLC
LSE:MIDW
|
UK |
|
ImpediMed Ltd
ASX:IPD
|
AU |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
ID |
|
S
|
Science Applications International Corp
F:85S
|
US |
|
Prospa Group Ltd
ASX:PGL
|
AU |
|
Farmers Edge Inc
TSX:FDGE
|
CA |
|
Atco Ltd
OTC:ACLLF
|
CA |
|
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
MY |
Wall St Price Targets
COC Price Targets Summary
L'Occitane International SA
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is COC's stock price target?
Not Available
COC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for L'Occitane International SA?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 2 years is 14%.
What is the Operating Income forecast for L'Occitane International SA?
Projected CAGR
24%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 2 years is 24%.
What is the Net Income forecast for L'Occitane International SA?
Projected CAGR
82%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 2 years is 82%.
